Synthesis and antiviral activity evaluation of some aminoadamantane derivatives. 1994

N Kolocouris, and G B Foscolos, and A Kolocouris, and P Marakos, and N Pouli, and G Fytas, and S Ikeda, and E De Clercq
Department of Pharmacy, University of Athens, Greece.

The synthesis of some spiro[cyclopropane-1,2'-adamantan]-2-amines and methanamines and some spiro[pyrrolidine-2,2'-adamantanes] is described. The title compounds were evaluated against a wide range of viruses (influenza A, influenza B, parainfluenza 3, RSV, HSV-1, TK- HSV-1, HSV-2, vaccinia, vesicular stomatitis, polio 1, coxsackie B4, sindbis, semliki forest, Reo 1, HIV-1, and HIV-2), and some of them (compounds 6b, 6c, 9a, 16a, 16b, and 17) inhibited the cytopathicity of influenza A virus at a concentration significantly lower than that of amantadine and also significantly lower than the concentrations at which they proved cytotoxic to the host cells. None of the new aminoadamantane derivatives was active against influenza B virus or any of the other viruses tested, which points to their specificity as anti-influenza A virus agents.

UI MeSH Term Description Entries
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000218 Adamantane A tricyclo bridged hydrocarbon. Diamantane
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

N Kolocouris, and G B Foscolos, and A Kolocouris, and P Marakos, and N Pouli, and G Fytas, and S Ikeda, and E De Clercq
May 1968, Journal of medicinal chemistry,
N Kolocouris, and G B Foscolos, and A Kolocouris, and P Marakos, and N Pouli, and G Fytas, and S Ikeda, and E De Clercq
March 2008, Journal of medicinal chemistry,
N Kolocouris, and G B Foscolos, and A Kolocouris, and P Marakos, and N Pouli, and G Fytas, and S Ikeda, and E De Clercq
December 1993, Arzneimittel-Forschung,
N Kolocouris, and G B Foscolos, and A Kolocouris, and P Marakos, and N Pouli, and G Fytas, and S Ikeda, and E De Clercq
January 1973, Acta microbiologica Academiae Scientiarum Hungaricae,
N Kolocouris, and G B Foscolos, and A Kolocouris, and P Marakos, and N Pouli, and G Fytas, and S Ikeda, and E De Clercq
August 2003, Bioorganic & medicinal chemistry,
N Kolocouris, and G B Foscolos, and A Kolocouris, and P Marakos, and N Pouli, and G Fytas, and S Ikeda, and E De Clercq
February 2002, Chemical & pharmaceutical bulletin,
N Kolocouris, and G B Foscolos, and A Kolocouris, and P Marakos, and N Pouli, and G Fytas, and S Ikeda, and E De Clercq
August 2014, Acta pharmaceutica Sinica. B,
N Kolocouris, and G B Foscolos, and A Kolocouris, and P Marakos, and N Pouli, and G Fytas, and S Ikeda, and E De Clercq
September 2015, European journal of medicinal chemistry,
N Kolocouris, and G B Foscolos, and A Kolocouris, and P Marakos, and N Pouli, and G Fytas, and S Ikeda, and E De Clercq
December 2006, Archiv der Pharmazie,
N Kolocouris, and G B Foscolos, and A Kolocouris, and P Marakos, and N Pouli, and G Fytas, and S Ikeda, and E De Clercq
August 2008, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!